rash from glp 1 Hypersensitivity to glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like to dulaglutide and literature review - Bianchi - 2024 - JEADV Clinical Practice Delayed type hypersensitivity injection site

Community research peptide protocols use 1.5 mg/week total roughly 60% of the FDA starting dose and 10% of the maximum

However, peptides may enhance the biological healing that makes physical therapy more productive

"O-Glycosylated 24 kDa human growth hormone has a mucin-like biantennary disialylated tetrasaccharide attached at Thr-60"

Before Starting GLP-1 Assess the 4 Drivers of Health Metabolism, Hormones, Inflammation, Recovery Identify which internal drivers are contributing to weight gain Establish baseline metabolic and hormonal markers Set realistic expectations for the medication AND the work that needs to happen alongside it During GLP-1 Treatment Use the appetite window to build sustainable eating habits (not just eat less) Incorporate strength training to preserve muscle mass Address underlying metabolic and hormonal factors in parallel Support gut health and reduce inflammation Improve sleep and manage stress Monitor metabolic markers to track internal improvement, not just weight Transitioning Off GLP-1 Gradual dose reduction rather than abrupt stopping Metabolic and hormonal markers re-assessed Sustainable habits tested without medication support Continued monitoring and adjustment The goal is to use the medication as a bridge creating a window of reduced appetite and improved insulin sensitivity while the real work of changing the internal environment happens underneath

The final result usually shows up a few days after you get injected